{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:38:50Z","timestamp":1791837530998,"version":"4.3.4"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.dsx.2017.03.038","type":"journal-article","created":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T23:17:37Z","timestamp":1491088657000},"page":"S473-S475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"S1","title":["Assessment of cardiovascular risk via atherogenic indices in patients with bipolar disorder manic episode and alterations with treatment"],"prefix":"10.1016","volume":"11","author":[{"given":"Tevfik","family":"Kalelioglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Genc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrin","family":"Karamustafalioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Emul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2017.03.038_bib0005","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11920-014-0499-z","article-title":"Excess Mortality in Bipolar Disorders","volume":"16","author":"Miller","year":"2014","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.dsx.2017.03.038_bib0010","first-page":"240","article-title":"Atherogenic index of plasma (AIP): a marker of cardiovascular disease","volume":"29","author":"Niroumand","year":"2015","journal-title":"Med J Islam Repub Iran"},{"key":"10.1016\/j.dsx.2017.03.038_bib0015","first-page":"12","article-title":"Atherogenic index of plasma, castelli risk indexes and Leptin\/Adiponectin ratio in women with metabolic syndrome","volume":"3","author":"Koleva","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.dsx.2017.03.038_bib0020","first-page":"39","article-title":"Novel lipid indices in chronic kidney disease","volume":"5","author":"Mannangi","year":"2015","journal-title":"Natl J Med Res"},{"key":"10.1016\/j.dsx.2017.03.038_bib0025","first-page":"359","article-title":"Atherogenic index of plasma, castelli risk index and atherogenic coefficient \u2013 new parameters in assessing cardiovascular risk","volume":"3","author":"Bhardwaj","year":"2013","journal-title":"Int J Pharm Biol Sci"},{"key":"10.1016\/j.dsx.2017.03.038_bib0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jad.2014.09.038","article-title":"Atherogenic index of plasma and atherogenic coefficient are increased in major depression and bipolar disorder, especially when comorbid with tobacco use disorder","volume":"172","author":"Nunes","year":"2015","journal-title":"J Affect Disord"},{"key":"10.1016\/j.dsx.2017.03.038_bib0035","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jad.2013.08.004","article-title":"The nesfatin 1 level in male patients with manic episode and alterations of nesfatin 1 level after antipsychotic and electroconvulsive treatment","volume":"151","author":"Emul","year":"2013","journal-title":"J Affect Disord"},{"key":"10.1016\/j.dsx.2017.03.038_bib0040","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/0269881105058678","article-title":"Metabolism, lifestyle and bipolar affective disorder","volume":"19","author":"Morriss","year":"2005","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.dsx.2017.03.038_bib0045","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.2174\/1381612821666150619093128","article-title":"Emerging drugs and indications for cardio-metabolic disorders in people with severe mental illness","volume":"21","author":"Kouidrat","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.dsx.2017.03.038_bib0050","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/0091270010368678","article-title":"Effect of antipsychotic medications on glucose and lipid levels","volume":"51","author":"Chaggar","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.dsx.2017.03.038_bib0055","first-page":"414","article-title":"Metabolic syndrome in Tunisian bipolar I patients","volume":"11","author":"Ezzaher","year":"2011","journal-title":"Afr Health Sci"},{"key":"10.1016\/j.dsx.2017.03.038_bib0060","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.genhosppsych.2015.04.003","article-title":"Increased risk of hyperlipidemia in patients with bipolar disorder: a population-based study","volume":"37","author":"Hsu","year":"2015","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.dsx.2017.03.038_bib0065","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1034\/j.1399-5618.2000.020109.x","article-title":"Cholesterol levels in mood disorders: high or low?","volume":"2","author":"Ghaemi","year":"2000","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.dsx.2017.03.038_bib0070","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000067809","article-title":"Serum leptin and cholesterol levels in patients with bipolar disorder","volume":"46","author":"Atmaca","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.dsx.2017.03.038_bib0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.lfs.2014.02.033","article-title":"Castelli risk indexes 1 and 2 are higher in major depression but other characteristics of the metabolic syndrome are not specific to mood disorders","volume":"102","author":"Vargas","year":"2014","journal-title":"Life Sci"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402117300528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402117300528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T21:57:17Z","timestamp":1535925437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402117300528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":15,"alternative-id":["S1871402117300528"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2017.03.038","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of cardiovascular risk via atherogenic indices in patients with bipolar disorder manic episode and alterations with treatment","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2017.03.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}